Boehringer Ingelheim Biopharma Contract Manufacturing has now evolved into Boehringer Ingelheim BioXcellence.
The new brand provides the production technology chain from DNA to fill and finish at its facilities in Biberach (Germany), Vienna (Austria) and Fremont (USA).
Boehringer Ingelheim biopharmaceuticals senior vice president Simon Sturge said, "Our new brand Boehringer Ingelheim BioXcellence will help our customers and the market identify with the quality and reliability which has made Boehringer Ingelheim’s biopharmaceutical contract manufacturing business one of the largest in the world."
Boehringer Ingelheim BioXcellence can secure product supply throughout the entire product lifecycle, transferring customer projects at any stage, delivering to any scale, according to the company.